Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Open Access
- 1 September 1993
- journal article
- abstracts
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 268 (26), 19650-19655
- https://doi.org/10.1016/s0021-9258(19)36565-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)Nature, 1993
- Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormoneTrends in Endocrinology & Metabolism, 1992
- Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranesFEBS Letters, 1992
- Characterization of glucagon-like peptide-I(7-36)amide receptors of rat lung membranes by covalent cross-linkingFEBS Letters, 1991
- Characterization of receptors for glucagon‐like peptide‐1(7–36) amide on rat lung membranesFEBS Letters, 1990
- Characterization of the receptor for glucagon-like peptide-1(7–36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linkingJournal of Molecular Endocrinology, 1989
- Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP‐ and secretin‐like properties (helodermin) from Gila monster venomFEBS Letters, 1984
- The incretin concept todayDiabetologia, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970